% | $
Quotes you view appear here for quick access.

IntelGenx Technologies Corp. Message Board

  • bernsteinjoshi bernsteinjoshi Jun 18, 2013 12:09 PM Flag

    IGXT gets NDA acceptance for their UNIQUE Anti-Migraine oral strip !!!

    This is from SA :

    " however let's look at the most promising drug in the pipeline which is the anti-migraine drug. This is a $2bn US market with current treatments which I see as basically similar. Then you have IntelGenx with a novel oral strip formulation of the very popular Maxalt (marketed by Merck and now off patent) which sold more than $600m last year. What people need to focus is that when a new formulation comes in the market; it may also expand and captures market share from pretty similar drugs if it works. Patients who have migraine issues need faster onset of action rather than better pricing and doctors are looking for drugs that are safe, fast and efficacious. People don't die from migraine but if you ever had it, you don't care how much it costs, as long as it works. I believe this anti-migraine product could be a $200-300m product at peak revenues and the timing is perfect given that I don't expect any new drugs to hit the market in the next 2-3 years. This is a 2014 event for IntelGenx and it could be important for the company history."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.815+0.038(+4.82%)Aug 26 3:56 PMEDT